Breast cancer death rates globally to rise 68% by 2050: WHO arm IARC warns
Annual deaths caused by breast cancer globally will rise 68% to 1.1 million by 2050, according to a report from the International Agency.
Drugs
Health
Pharma
Health
Medical
Pharma
Medtronic Plc’s neurostimulator for Parkinson’s gets USFDA approval
Ireland’s Medtronic Plc’s deep brain stimulation device for patients with Parkinson’s disease has been approved by the US Food and Drug Administration, according.
Health
Medical
Pharma
Saudi Arabia reaffirms $500 million pledge to eradicate polio
Saudi Arabia has reaffirmed a $500 million pledge to the WHO’s Global Polio Eradication Initiative to fight the disease plaguing vulnerable children, according.
Health
Research
Covid-like virus HKU5 discovered by China’s Wuhan Institute scientists
HQ Team February 24, 2025: Chinese virologists at the Wuhan Institute of Virology have found another bat coronavirus that carries the risk of.
Health
Medical
Pharma
KKR to acquire majority stake in India’s HCG for $400 million
US-based private equity and advisory investment firm KKR & Co. Inc. will pay CVC Capital Partners $400 million to acquire a majority stake.
Drugs
Health
Medical
US regulator clears Mirum’s oral drug for reducing cholesterol deposits
Mirum Pharmaceuticals Inc.’s oral cholesterol drug for treating a rare metabolic disease has been approved by the Food and Drug Administration.
Drugs
Health
Artificial sweeteners spike insulin levels, increasing risk of heart diseases
HQ Team February 21, 2025: Artificial sweeteners, long used as low-calorie alternatives to sugar, are known to cause a number of health conditions,.
Climate
Health
Research
Cambridge researchers develop solar reactor to make fuel from CO2
Cambridge researchers have developed a reactor that pulls carbon dioxide directly from the air and converts it into sustainable fuel, using sunlight as.
Health
Medical
Pharma
UN humanitarian aid system facing ‘greatest test’ since creation: Relief chief
The international humanitarian aid system of the United Nations, set up after the Second World War, is facing the “greatest test since creation”.
Drugs
Health
Pharma
AstraZeneca Plc buys China unit of FibroGen Inc for $160 million
HQ Team February 21, 2025: FibroGen Inc., a US-based pharmaceutical company, will sell its China subsidiary to AstraZeneca Plc. for $160 million, allowing.